
CTCA Before ICA Reduces Procedure Time And Contrast-Induced Nephropathy Risk Among Patients With Previous CABG
- byDoctor News Daily Team
- 18 February, 2025
- 0 Comments
- 0 Mins

In a game-changing study, researchers have discovered a more effective approach for patients with previous coronary artery bypass grafting (CABG). Traditional invasive coronary angiography (ICA) for these patients often poses challenges and risks. However, a pioneering trial, the first of its kind, introduced computed tomography cardiac angiography (CTCA) as an adjunct before ICA as it minimizes procedural time and contrast-induced nephropathy.
The study results were published in the journal Circulation.
Also Read: Add on Fundus resection to typical laparoscopic Roux-en-Y gastric bypass offers no superior glycemic control in T2DM
Individuals with prior coronary artery bypass grafting often need invasive coronary angiography (ICA). Yet, this procedure poses increased technical challenges and higher complication risks for them. Observational research indicates that computed tomography cardiac angiography (CTCA) might aid ICA in this population. However, no randomized controlled trial has validated this approach. Hence researchers conducted a randomized controlled trial called The BYPASS-CTCA Trial to assess the benefit of adjunctive CTCA in patients with previous coronary artery bypass grafting referred for ICA.
In this single-center, open-label randomized controlled trial, patients were evenly divided into two groups: one undergoing CTCA before ICA, and the other undergoing ICA alone. Primary outcomes encompass ICA procedural duration, patient satisfaction measured through a validated questionnaire, and the occurrence of contrast-induced nephropathy. Statistical analyses employed linear regression for procedural duration and patient satisfaction, while logistic regression was used for contrast-induced nephropathy. Significance was determined with P<0.017 and 98.33% confidence intervals. Secondary endpoints included procedural complications and major adverse cardiac events over one year.
Key findings:
Over a three-year period, 688 patients were randomly assigned, with a median follow-up of 1.0 years.
The average age was 69.8±10.4 years; 108 (15.7%) were female, and 402 (58.4%) were White.
The group had a high prevalence of comorbidities, with 85.3% having hypertension and 53.8% having diabetes.
The median duration from coronary artery bypass grafting to angiography was 12.0 years, and participants had a median of 3 grafts each.
In the CTCA+ICA group, the ICA procedure was significantly shorter taking 18.6±9.5 minutes, ICA alone took 39.5±16.9 minutes.
Shorter duration led to improved ICA satisfaction scores, and reduced incidence of contrast-induced nephropathy (3.4% vs. 27.9%).
The CTCA+ICA group also experienced fewer procedural complications (2.3% vs. 10.8%) and lower rates of major adverse cardiac events at one year (16.0% vs. 29.4%).
Also Read: Management of patients with chronic coronary disease: Latest recommendations of ACC/AHA
Thus, this groundbreaking research signifies a paradigm shift, offering a safer, more efficient path for patients with previous CABG. Considering these compelling outcomes, integrating CTCA before ICA emerges as a promising standard of care for this patient group, revolutionizing heart health management.
Further reading: Jones DA, Beirne AM, Kelham M, et al. Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial. Circulation. doi:10.1161/CIRCULATIONAHA.123.064465
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.

Recent News
Normal-Tension Glaucoma Closely Associated With Co...
- 10 October, 2022
Air Pollution Tied To Increased Risk Of Premature...
- 24 May, 2023
NEET PG 2024: NBE Opens Pre-Final Edit Window
- 30 May, 2024

Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!